CG
KYNB

Cutler Group’s Kyntra Bio KYNB Stock Holding History

Cutler Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2K Sell
36
-100
-74% -$4.31K ﹤0.01% 1834
2023
Q4 		$3K Hold
136
– – ﹤0.01% 2946
2023
Q3 		$2K Sell
136
-288
-68% -$11.3K ﹤0.01% 3249
2023
Q2 		$28K Buy
424
+324
+324% +$134K ﹤0.01% 1637
2023
Q1 		$46K Sell
100
-56
-36% -$29.6K ﹤0.01% 1400
2022
Q4 		$62K Sell
156
-4
-3% -$1.53K 0.01% 1437
2022
Q3 		$52K Hold
160
– – ﹤0.01% 1860
2022
Q2 		$42K Sell
160
-53
-25% -$13.5K ﹤0.01% 2064
2022
Q1 		$63K Sell
213
-1,068
-83% -$372K ﹤0.01% 2059
2021
Q4 		$451K Buy
1,281
+957
+295% +$298K 0.02% 803
2021
Q3 		$82K Buy
324
+84
+35% +$29.8K ﹤0.01% 2089
2021
Q2 		$159K Buy
+240
New +$138K 0.01% 1505
2020
Q2 		– Sell
-40
Closed -$37.1K – 4526
2020
Q1 		$34K Sell
40
-389
-91% -$387K ﹤0.01% 1964
2019
Q4 		$460K Buy
429
+363
+550% +$371K 0.03% 474
2019
Q3 		$61K Buy
66
+62
+1,550% +$68.1K 0.01% 1393
2019
Q2 		$4K Sell
4
-166
-98% -$182K ﹤0.01% 3215
2019
Q1 		$230K Sell
170
-108
-39% -$146K 0.02% 591
2018
Q4 		$321K Buy
+278
New +$312K 0.03% 454
2018
Q3 		– Sell
-32
Closed -$49.3K – 4281
2018
Q2 		$50K Buy
32
+12
+60% +$15.6K ﹤0.01% 1607
2018
Q1 		$23K Sell
20
-388
-95% -$511K ﹤0.01% 2179
2017
Q4 		$482K Sell
408
-376
-48% -$471K 0.02% 558
2017
Q3 		$1.05M Sell
784
-189
-19% -$199K 0.04% 333
2017
Q2 		$786K Buy
973
+528
+119% +$368K 0.03% 494
2017
Q1 		$273K Sell
445
-288
-39% -$175K 0.01% 980
2016
Q4 		$392K Buy
733
+24
+3% +$12K 0.01% 840
2016
Q3 		$366K Sell
709
-1,109
-61% -$522K 0.02% 773
2016
Q2 		$745K Buy
1,818
+1,488
+451% +$681K 0.04% 402
2016
Q1 		$175K Buy
+330
New +$164K 0.01% 1103

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cutler Group's KYNB Position: Q1 2024 in Review

Cutler Group reduced its Kyntra Bio (KYNB) stake by 74% in Q1 2024, selling an estimated $4.31K and leaving 36 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Cutler Group first reported a position in KYNB in Q1 2016 and has held it in 28 quarters since. The position peaked at $1.05M in Q3 2017. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Cutler Group held 36 shares of Kyntra Bio worth $2K as of Q1 2024.
  • Cutler Group sold 100 Kyntra Bio shares in Q1 2024, an estimated $4.31K.
  • Kyntra Bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1834 holding.
  • Cutler Group first reported a position in Kyntra Bio in Q1 2016 and has held it in 28 quarters since.
  • Cutler Group's Kyntra Bio position peaked at $1.05M in Q3 2017.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.